QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=6786E3DFE84EB9E8E17DEF285DCC3349;jsessionid=0A67D1D8F60D4C29D9D57C3D1E5B147F;jsessionid=75EB2F945B93DBA803465299A6F10967;jsessionid=F5D115B93E2548548959ED66974630D1;jsessionid=C2B3702F5CE4811820D759EFF2EF56DD;jsessionid=798019EAB8D885E08F381CCBEA8B83D1;jsessionid=C6EA30DCA3EFD9225A38C4DCB58FD4BC (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=6786E3DFE84EB9E8E17DEF285DCC3349;jsessionid=0A67D1D8F60D4C29D9D57C3D1E5B147F;jsessionid=75EB2F945B93DBA803465299A6F10967;jsessionid=F5D115B93E2548548959ED66974630D1;jsessionid=C2B3702F5CE4811820D759EFF2EF56DD;jsessionid=798019EAB8D885E08F381CCBEA8B83D1;jsessionid=C6EA30DCA3EFD9225A38C4DCB58FD4BC